Connect with us

    Hi, what are you looking for?

    News

    MultiChoice loses $1.7b in six months

    MultiChoice
    Multichoice Nigeria

    MultiChoice investors lose R32 billion ($1.7 billion) in six months as it struggles to retain high-end subscribers and find new revenue sources.

    At the start of March 2023, MultiChoice’s share price exceeded R147 ($7.86). On March 13, when it issued a warning that the revenue growth in its South African business would fall short of expectations, it decreased to about R120 ($6.41) per share.

    Due to its fixed cost base and additional Showmax expenses, it had a significantly lower trading margin. At that point, a six-month decline that cost the market cap billions of dollars started.

    One of MultiChoice’s biggest problems is the continued cancellation of South Africans’ DStv subscriptions, particularly in the Premium and Mid-market segments.

    The impact can be seen in DStv’s average revenue per user, which dropped from R269 ($14.38) to R256 ($13.69) year over year.

    What’s the way forward? The company is looking for new revenue streams to offset the decline in high-end subscribers. This plan includes selling Internet packages, investing billions in its Showmax streaming service, and acquiring a large stake in sports betting service KingMakers.

    Spread the love
    Click to comment

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    ad

    You May Also Like

    News

    The Enugu State Government has accused Olasijibomi Ogundele, CEO of Sujimoto Luxury Construction Limited, of defrauding the state of N5.7 billion paid for the...

    News

    China is expected to unveil what it claims is “the most powerful laser air defence system in the world” during a major military parade...

    Tech

    Twenty Nigerian media professionals and digital creators are embarking on a week-long study trip to South Africa as part of the MTN Media Innovation...

    Health

    National Food, Drug Administration and Control NAFDAC has alerted the public on the circulation of an unregistered Gold Vision Oxytocin injection 10IU with a...